Temozolomide-induced increase of tumorigenicity can be diminished by targeting of mitochondria in in vitro models of patient individual glioblastoma
Disentangling the therapeutic tactics in GBM: From bench to bedside and beyond - Daisy Precilla - 2021 - Cell Biology International - Wiley Online Library
Voltammetric/UV–Vis study of temozolomide inclusion complexes with cyclodextrin derivatives - ScienceDirect
Upregulation of CYP17A1 by Sp1-mediated DNA demethylation confers temozolomide resistance through DHEA-mediated protection in glioma | Oncogenesis
Biomedicines | Free Full-Text | Temozolomide and Other Alkylating Agents in Glioblastoma Therapy | HTML
Transcriptional control of O6‐methylguanine DNA methyltransferase expression and temozolomide resistance in glioblastoma - Happold - 2018 - Journal of Neurochemistry - Wiley Online Library
Novel dopamine receptor 3 antagonists inhibit the growth of primary and temozolomide resistant glioblastoma cells
PDF) Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival
Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival | BMC Neurology | Full Text
Bortezomib administered prior to temozolomide depletes MGMT, chemosensitizes glioblastoma with unmethylated MGMT promoter and prolongs animal survival | British Journal of Cancer
Effect of long-term adjuvant temozolomide chemotherapy on primary glioblastoma patient survival | BMC Neurology | Full Text
Frontiers | C8-Substituted Imidazotetrazine Analogs Overcome Temozolomide Resistance by Inducing DNA Adducts and DNA Damage | Oncology
Integrated genetic and metabolic landscapes predict vulnerabilities of temozolomide resistant glioblastoma cells | npj Systems Biology and Applications
Up-regulation of miR-370-3p restores glioblastoma multiforme sensitivity to temozolomide by influencing MGMT expression | Scientific Reports
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial - The Lancet Oncology
Cells | Free Full-Text | Intracellular Redox-Balance Involvement in Temozolomide Resistance-Related Molecular Mechanisms in Glioblastoma | HTML
Elucidating the mechanisms of Temozolomide resistance in gliomas and the strategies to overcome the resistance. - ScienceDirect
Association of patterns of care, prognostic factors, and use of radiotherapy–temozolomide therapy with survival in patients with newly diagnosed glioblastoma: a French national population-based study | SpringerLink
Frontiers | Immune Escape in Glioblastoma Multiforme and the Adaptation of Immunotherapies for Treatment | Immunology
Identification of a transient state during the acquisition of temozolomide resistance in glioblastoma | Cell Death & Disease
Capecitabine and temozolomide in grade 1/2 neuroendocrine tumors: a Spanish multicenter experience | Future Oncology
Biomedicines | Free Full-Text | Temozolomide and Other Alkylating Agents in Glioblastoma Therapy | HTML
Genistein and Temozolomide-Loaded Polymeric Nanoparticles: A Synergistic Approach For Improved Anti-Tumor Efficacy Against Glioblastoma - ScienceDirect
